The University of Queensland

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551

Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Goel, Gautam, King, Tim, Daveson, A. James, Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J. E., Fogel, Ronald, Barish, Charles F., Epstein, Roger, Kinney, Timothy P., Miner Jr, Philip B., Girardin, Adam, Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Maki, Makku, Goldstein, Kaela E., Griffin, Patrick H., Wang, Suyue, Dzuris, John L., Williams, Leslie J., Sette, Alessandro, Xavier, Ramnik J., Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2017). Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology, 2 (7), 479-493. doi: 10.1016/S2468-1253(17)30110-3

Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trial

Daveson, A. James, Jones, Dianne M., Gaze, Soraya, McSorley, Henry, Clouston, Andrew, Pascoe, Andrew, Cooke, Sharon, Speare, Richard, Macdonald, Graeme A., Anderson, Robert, McCarthy, James S., Loukas, Alex and Croese, John (2011). Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trial. PLoS One, 6 (3, Article number e17366) e17366, e17366-1-e17366-9. doi: 10.1371/journal.pone.0017366

Future perspectives of small bowel capsule endoscopy

Daveson, James and Appleyard, Mark (2008). Future perspectives of small bowel capsule endoscopy. New Challenges in Gastrointestinal Endoscopy. (pp. 262-270) Tokyo, Japan: Springer Japan. doi: 10.1007/978-4-431-78889-8_26

Splenic artery collateral masquerading as a gastric varix post splenic trauma

Daveson, A.J.M., O’Rourke, T. and Davis, S. (2024). Splenic artery collateral masquerading as a gastric varix post splenic trauma. Gastrointestinal Endoscopy, 99 (1), 120-121. doi: 10.1016/j.gie.2023.07.004

Undiagnosed coeliac disease identified by active case finding in first degree relatives of people with coeliac disease in Australia: a prospective observational study

Muir, Richard, Sehgal, Anuj, Tye‐Din, Jason A and Daveson, A James M (2023). Undiagnosed coeliac disease identified by active case finding in first degree relatives of people with coeliac disease in Australia: a prospective observational study. Medical Journal of Australia, 219 (8), 371-373. doi: 10.5694/mja2.52105

High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday region

Flanagan, Amanda, Allsopp, Susan M., O'Connor, Sam A., Tobin, Jacinta, Pretorius, Casper, Brown, Ian S., Bell, Sally and Daveson, A. James M. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday region. Internal Medicine Journal, 53 (9), 1602-1609. doi: 10.1111/imj.15941

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

Tye-Din, Jason A, Daveson, A James M, Goel, Gautam, Goldstein, Kaela E, Hand, Holly L, Neff, Kristin M, Popp, Alina, Taavela, Juha, Maki, Markku, Isola, Jorma, Williams, Leslie J, Truitt, Kenneth E, Anderson, Robert P, Adams, Atoya, Andrews, Jane M, Behrend, Clint E, Brown, Gregor J E, Chen Yi Mei, Swee Lin, Coates, Allan G, DiMarino, Anthony J, Ee, Hooi, Elliott, David E, Epstein, Roger M, Feyen, Bryan John, Fogel, Ronald P, Friedenberg, Keith Alan, Gearry, Richard B, Gerdis, Michael S, Goldstein, Michael J ... Wilson, Scott A (2023). Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. The Lancet Gastroenterology and Hepatology, 8 (5), 446-457. doi: 10.1016/s2468-1253(22)00428-9

Tattoo sarcoidosis presenting as abdominal allodynia

Faint, Annabelle and Daveson, A. James M. (2022). Tattoo sarcoidosis presenting as abdominal allodynia. Medical Journal of Australia, 217 (1), 23-23. doi: 10.5694/mja2.51603

Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease

Tye-Din, Jason A., Daveson, A. James M., Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Goel, Gautam, Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., RESET CeD Study Group and Holtmann, G. (2020). Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC medicine, 18 (1) 362, 362. doi: 10.1186/s12916-020-01828-y

Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply

Daveson, A. James M., Tye-Din, Jason A. and Anderson, Robert P. (2020). Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply. Alimentary Pharmacology and Therapeutics, 51 (3), 403-404. doi: 10.1111/apt.15629

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551

Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease

Goel, G., Daveson, A. J. M., Hooi, C. E., Tye-Din, J. A., Wang, S., Szymczak, E., Williams, L. J., Dzuris, J. L., Neff, K. M., Truitt, K. E. and Anderson, R. P. (2019). Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease. Clinical and Experimental Immunology, 199 (1) cei.13369, 68-78. doi: 10.1111/cei.13369

Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease

Tye-Din, Jason A., Daveson, A. James M., Ee, Hooi C., Goel, Gautam, MacDougall, James, Acaster, Sarah, Goldstein, Kaela E., Dzuris, John L., Neff, Kristin M., Truitt, Kenneth E. and Anderson, Robert P. (2019). Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Alimentary Pharmacology and Therapeutics, 50 (8), 901-910. doi: 10.1111/apt.15477

Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease

Truitt, Kenneth E., Daveson, A. James M., Ee, Hooi C., Goel, Gautam, MacDougall, James, Neff, Kristin and Anderson, Robert P. (2019). Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. Alimentary Pharmacology & Therapeutics, 50 (5), 547-555. doi: 10.1111/apt.15435

High rates of variation in HLA-DQ2/DQ8 testing for coeliac disease: results from an RCPAQAP pilot program

Horan, Martin Patrick, Chai, Sze Yee, Munusamy, Nalishia, Tay, Kwang Hong, Wienholt, Louise, Tye-Din, Jason A, Daveson, James, Varney, Michael and Badrick, Tony (2018). High rates of variation in HLA-DQ2/DQ8 testing for coeliac disease: results from an RCPAQAP pilot program. Journal of Clinical Pathology, 71 (10), jclinpath-2018. doi: 10.1136/jclinpath-2018-205209

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

Daveson, A. James M., Ee, Hooi C., Andrews, Jane M., King, Timothy, Goldstein, Kaela E., Dzuris, John L., MacDougall, James A., Williams, Leslie J., Treohan, Anita, Cooreman, Michael P. and Anderson, Robert P. (2017). Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. EBioMedicine, 26, 78-90. doi: 10.1016/j.ebiom.2017.11.018

Discrepancies in genetic testing results for coeliac disease: call for standardised testing and reporting

Daveson, A. James M. , Varney, Michael, Jackson, Kate E. and Tye-Din, Jason A. (2017). Discrepancies in genetic testing results for coeliac disease: call for standardised testing and reporting. Medical Journal Australia, 207 (4), 179-180. doi: 10.5694/mja17.00314

Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Goel, Gautam, King, Tim, Daveson, A. James, Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J. E., Fogel, Ronald, Barish, Charles F., Epstein, Roger, Kinney, Timothy P., Miner Jr, Philip B., Girardin, Adam, Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Maki, Makku, Goldstein, Kaela E., Griffin, Patrick H., Wang, Suyue, Dzuris, John L., Williams, Leslie J., Sette, Alessandro, Xavier, Ramnik J., Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2017). Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology, 2 (7), 479-493. doi: 10.1016/S2468-1253(17)30110-3

Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective

Tye-Din, J. A., Cameron, D. J. S., Daveson, A. J., Day, A. S., Dellsperger, P., Hogan, C., Newnham, E. D., Shepherd, S. J., Steele, R. H., Wienholt, L. and Varney, M. D. (2015). Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Internal Medicine Journal, 45 (4), 441-450. doi: 10.1111/imj.12716

Small bowel endoscopy and coeliac disease

Daveson, A. James M. and Anderson, Robert P. (2012). Small bowel endoscopy and coeliac disease. Best Practice and Research: Clinical Gastroenterology, 26 (3), 315-323. doi: 10.1016/j.bpg.2012.03.004

Characterising the mucosal and systemic immune responses to experimental human hookworm infection

Gaze, Soraya, McSorley, Henry J., Daveson, James, Jones, Di, Bethony, Jeffrey M., Oliveira, Luciana M., Speare, Richard, McCarthy, James S., Engwerda, Christian R., Croese, John and Loukas, Alex (2012). Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathogens, 8 (2) e1002520, e1002520. doi: 10.1371/journal.ppat.1002520

Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection

McSorley, Henry J., Gaze, Soraya, Daveson, James, Jones, Dianne, Anderson, Robert P., Clouston, Andrew, Ruyssers, Nathalie E., Speare, Richard, McCarthy, James S., Engwerda, Christian R., Croese, John and Loukas, Alex (2011). Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One, 6 (9) e24092, e24092-1-e24092-7. doi: 10.1371/journal.pone.0024092

Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trial

Daveson, A. James, Jones, Dianne M., Gaze, Soraya, McSorley, Henry, Clouston, Andrew, Pascoe, Andrew, Cooke, Sharon, Speare, Richard, Macdonald, Graeme A., Anderson, Robert, McCarthy, James S., Loukas, Alex and Croese, John (2011). Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trial. PLoS One, 6 (3, Article number e17366) e17366, e17366-1-e17366-9. doi: 10.1371/journal.pone.0017366

A case of periportal fibrosis in a Sudanese refugee

Daveson , James and Macdonald, Graeme (2008). A case of periportal fibrosis in a Sudanese refugee. Medical Journal of Australia, 188 (11), 677-678. doi: 10.5694/j.1326-5377.2008.tb01834.x

A case of an isolated gastric variceal bleed secondary to a pancreatic neuroendocrine tumour

Daveson, James, Masson, John, Cameron, Donald and Jennings, Melissa (2007). A case of an isolated gastric variceal bleed secondary to a pancreatic neuroendocrine tumour. European Journal of Gastroenterology & Hepatology, 19 (12), 1144-1148. doi: 10.1097/MEG.0b013e32822a0b6a

Lack of Agreement Between 2 Methods of Measuring Hemoglobin

Daveson, Ajm and Colditz, PB (1993). Lack of Agreement Between 2 Methods of Measuring Hemoglobin. Journal of Paediatrics and Child Health, 29 (6), 459-460. doi: 10.1111/j.1440-1754.1993.tb03020.x

High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region

Flanagan, A., O'Connor, S., Allsop, S., Tobin, J., Pretorius, C., Brown, I., Bell, S. and Daveson, A. J. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. OXFORD: OXFORD UNIV PRESS.

High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region

Flanagan, A., O'Connor, S., Allsop, S., Tobin, J., Pretorius, C., Brown, I., Bell, S. and Daveson, A. J. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.1010

Disaccharidase deficiency at time of diagnosis of coeliac disease, with rates of mucosal healing at surveillance endoscopy

Shelley, L., Jacobs, A. and Daveson, A. J. M. (2016). Disaccharidase deficiency at time of diagnosis of coeliac disease, with rates of mucosal healing at surveillance endoscopy. HOBOKEN: WILEY-BLACKWELL.

Nutrient deficiencies are common at the time of diagnosing coeliac disease in an Australian cohort

Shelley, L., Jacobs, A. and Daveson, A. J. M. (2016). Nutrient deficiencies are common at the time of diagnosing coeliac disease in an Australian cohort. HOBOKEN: WILEY-BLACKWELL.

A Single Intradermal (ID) Injection of Nexvax2 (R), a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+People With Celiac Disease (CeD)

Goel, Gautam, Mayassi, Toufic, Qiao, Shuo-Wang, Ciszewski, Cezary, King, Tim, Daveson, A. J., Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J., Fogel, Ron, Barish, Charles F., Epstein, Roger, Kinney, Timothy, Miner, Philip B., Tye-Din, Jason A., Girardin, Adam, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). A Single Intradermal (ID) Injection of Nexvax2 (R), a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+People With Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA), San Diego Ca, May 21-24, 2016. W B SAUNDERS CO-ELSEVIER INC.

A single intradermal (ID) injection of Nexvax (R), a peptide composition with dominant epitopes for gluten-reactive CD4+T Cells, activates T Cells and triggers acute gastrointestinal symptoms in HLA DQ2.5+ People with Celiac Disease (CeD)

Goel, G. and Daveson, J. (2016). A single intradermal (ID) injection of Nexvax (R), a peptide composition with dominant epitopes for gluten-reactive CD4+T Cells, activates T Cells and triggers acute gastrointestinal symptoms in HLA DQ2.5+ People with Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA),, San Diego, CA, United States, 21-24 May 2016.

Demyelination during infliximab therapy for crown's disease

An, Y. K., Allsop, S., Daveson, K.L. and Daveson, A. J. M. (2016). Demyelination during infliximab therapy for crown's disease. Australian Gastroenterology Week, Adelaide, SA, Australia, 10–12 October 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13522

Efficacy, safety, tolerability and immunological effects of Nexvax2®, a peptide-based therapeutic vaccine, administered by intra-dermal (ID) injection twice –weekly for 8 weeks in HLA-DQ2.5+ celiac disease (CeD)

Goel, Gautam, King, Tim, Daveson, A. J. M., Krishnarajah, Janakan, Brown, Gregor J., Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Maki, Markku, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). Efficacy, safety, tolerability and immunological effects of Nexvax2®, a peptide-based therapeutic vaccine, administered by intra-dermal (ID) injection twice –weekly for 8 weeks in HLA-DQ2.5+ celiac disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA),, San Diego, CA, United States, 21-24 May 2016. Maryland Heights, MO, United States: W.B. Saunders.

Nexvax2 (R), a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+People With Celiac Disease (CeD)

Goel, Gautam, Andrews, Jane M., Krause, Richard, Fogel, Ron, Barish, Charles F., Daveson, A. J., Epstein, Roger, King, Tim, Kinney, Timothy, Krishnarajah, Janakan, Miner, Philip B., Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Maki, Markku, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). Nexvax2 (R), a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+People With Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA), San Diego, California, United States, May 21-24, 2016. W B Saunders.

Concordance between numbers of duodenal biopsies collected at OGD and the number received for histological analysis

Taylor, S. and Daveson, A. J. (2015). Concordance between numbers of duodenal biopsies collected at OGD and the number received for histological analysis. HOBOKEN: WILEY-BLACKWELL.

Polyp prevalence in patients aged 50 years or less: a prospective single centre analysis

Al-Shinnag, M. and Daveson, J. A. (2015). Polyp prevalence in patients aged 50 years or less: a prospective single centre analysis. HOBOKEN: WILEY-BLACKWELL.

Pregnancy outcomes in patients with inflammatory bowel disease in a regional clinic

Allsopp, S. and Daveson, A. J. (2015). Pregnancy outcomes in patients with inflammatory bowel disease in a regional clinic. HOBOKEN: WILEY-BLACKWELL.

Video capsule endoscopy: can an Australian centre meet Capsule Endoscopy certification criteria for trainees?

Lee, J. Y., Tutticci, N. and Daveson, A. J. (2015). Video capsule endoscopy: can an Australian centre meet Capsule Endoscopy certification criteria for trainees?. HOBOKEN: WILEY-BLACKWELL.

An Assessment of the Diagnostic Utility of Coeliac Serology in an Australian Referral Centre

Muir, Richard, Smith, Ian and Daveson, A. James M. (2014). An Assessment of the Diagnostic Utility of Coeliac Serology in an Australian Referral Centre. 55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Chicago Il, May 03-06, 2014. W B SAUNDERS CO-ELSEVIER INC.

Poor interlaboratory reliability of coeliac antibodies: An Australian and New Zealand perspective on the ESPGHAN guidelines

Wienholt, L., Adelstein, S., Jovanovich, S., Steele, R., Tye-Din, J., Daveson, J. and Newnham, E. (2013). Poor interlaboratory reliability of coeliac antibodies: An Australian and New Zealand perspective on the ESPGHAN guidelines. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_7

Outcomes post double balloon enteroscopy - a report of the first 57 cases

Andelkovic, Melita, Jones, Dianne M. and Daveson, A. James M. (2012). Outcomes post double balloon enteroscopy - a report of the first 57 cases. Australian Gastroenterology Week 2012, Adelaide, SA Australia, 16-19 October 2012. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_4.x

Polyp prevalence at colonoscopy in patients aged 40 years or less: a prospective multisite analysis

Daveson, A. James M., Jones, Dianne M. and Hewett, David G. (2012). Polyp prevalence at colonoscopy in patients aged 40 years or less: a prospective multisite analysis. Australian Gastroenterology Week 2012, Adelaide, SA, Australia, 16-19 October 2012. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_3.x

A Phase 1 Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 (R) in HLA DQ2+Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free Diet

Brown, Gregor J., Daveson, James, Marjason, Joanne K., Ffrench, Rose A., Smith, Danielle, Sullivan, Mark, Tye-Din, Jason A. and Anderson, Robert P. (2011). A Phase 1 Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 (R) in HLA DQ2+Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free Diet. Conference on Digestive Disease Week 2011, Chicago Il, May 07-10, 2011. W B SAUNDERS CO-ELSEVIER INC.

A Randomized, Double Blinded, Placebo Controlled, Study Evaluating Immunity and Gluten-Sensitivity By Inoculating Coeliac Disease Patients with the Human Hookworm Necator Americanus

Daveson, A. James M., Jones, Dianne, McSorley, Henry, Gaze, Soraya, McCarthy, James, Clouston, Andrew D., Pascoe, Andrew, Macdonald, Graeme A., Speare, Richard, Cooke, Sharon E., Anderson, Robert P., Loukas, Alex and Croese, John (2009). A Randomized, Double Blinded, Placebo Controlled, Study Evaluating Immunity and Gluten-Sensitivity By Inoculating Coeliac Disease Patients with the Human Hookworm Necator Americanus. 110th Annual Meeting of the American Gastroenterological Association, Chicago, Illinois, 30 May - 4 June 2009 . Maryland Heights, MO, United States: W.B. Saunders Co..

A phase 2A randomized double blinded placebo controlled study evaluating immunity and gluten sensitivity by inoculating coeliac disease patients with the human hookworm necator americanus

Daveson, A. J. M., Jones, D., Mcsorley, H., Gaze, S., Mccarthy, J., Clouston, A., Pascoe, A., Macdonald, G., Speare, R., Anderson, R., Loukas, A and Croese, J. (2009). A phase 2A randomized double blinded placebo controlled study evaluating immunity and gluten sensitivity by inoculating coeliac disease patients with the human hookworm necator americanus. The Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, Sydney Convention & Exhibition Centre, Sydney, NSW, 21-24 October 2009. Carlton South, Vic: Wiley-Blackwell Publishing. doi: 10.1111/j.1440-1746.2009.06050.x